Login

Willkomen zurück, bitte gebe deine Zugangsdaten ein!

Passwort vergessen

Anmeldung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Centre proposes easier norms for faster drug rollout - The Economic Times

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug regulator. Import license processing timelines for new drugs will be halved to forty-five days. This move aims to improve the ease of doing business in the sector. However, certain high-risk drug categories will retain existing stringent requirements.

Ähnliche Seiten

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-notifies-navi-mumbai-airport-as-a-port-for-import-of-drugs-under-drug-rules/articleshow/132262795.cms

Government notifies Navi Mumbai Airport as a Port for Import of drugs under Drug Rules - The Economic Times

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-notifies-navi-mumbai-airport-as-a-port-for-import-of-drugs-under-drug-rules/articleshow/132262795.cms
https://economictimes.indiatimes.com/industry/banking/finance/banking/rbi-proposes-same-norms-of-disclosure-for-all-banks/articleshow/131210501.cms

RBI proposes same norms of disclosure for all banks - The Economic Times

https://economictimes.indiatimes.com/industry/banking/finance/banking/rbi-proposes-same-norms-of-disclosure-for-all-banks/articleshow/131210501.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/health-ministry-proposes-faster-approvals-for-medical-device-manufacturing-licences/articleshow/132047413.cms

Health ministry proposes faster approvals for medical device manufacturing licences - The Economic Times

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/health-ministry-proposes-faster-approvals-for-medical-device-manufacturing-licences/articleshow/132047413.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazenecas-enhertu-gets-regulatory-approval-in-india-for-first-line-her2-positive-breast-cancer/articleshow/131650857.cms

AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazenecas-enhertu-gets-regulatory-approval-in-india-for-first-line-her2-positive-breast-cancer/articleshow/131650857.cms
https://economictimes.indiatimes.com/news/india/et-world-leaders-forum-2026-boris-johnson-thanks-india-for-covid-vaccine-credits-brexit-for-uk-rollout/articleshow/133418213.cms

ET World Leaders Forum 2026: Boris Johnson thanks India for Covid vaccine, credits Brexit for UK rollout - The Economic Times

https://economictimes.indiatimes.com/news/india/et-world-leaders-forum-2026-boris-johnson-thanks-india-for-covid-vaccine-credits-brexit-for-uk-rollout/articleshow/133418213.cms
https://economictimes.indiatimes.com/markets/stocks/news/lupin-shares-in-focus-after-usfda-nod-for-drug-to-treat-excessive-daytime-sleepiness/articleshow/133310500.cms

Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepiness - The Economic Times

https://economictimes.indiatimes.com/markets/stocks/news/lupin-shares-in-focus-after-usfda-nod-for-drug-to-treat-excessive-daytime-sleepiness/articleshow/133310500.cms